These findings suggest that in resistant BCC, AP-1 shapes the chromatin accessibility landscape to open alternative Smad3 binding sites, allowing AP-1 and Smad3 to cooperatively induce expression of Rho regulators including GEFs. Here, JUNB is linked to skin basal cell carcinoma.